Skip to Main Content

Is China too enamored with biotech startups? Are activist investors more trouble than they’re worth? And can’t a billionaire spare more than a few million in the name of a flu vaccine?

We chew over all that and more in the latest episode of “The Readout LOUD,” STAT’s biotech podcast. Stay tuned for a chat with biotech investor Brad Loncar about Hong Kong’s impending biotech boom, a discussion of how consumer genetic testing relates to serial killers, and an exploration of Big Biotech’s existential crises. Also STAT’s Helen Branswell joins us to talk about Bill Gates arguably thrifty effort to find a universal flu vaccine.

For more on what we discuss, here’s a story on Hong Kong’s biotech affections; here’s a look at Biogen’s 40th birthday; here’s how authorities tracked down a suspect in a decades-long cold case; and here’s the deal with Gates’s flu fund.


We’ll be back next Thursday evening — and every Thursday evening — so be sure to sign up on iTunes, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

  • There were some sections of episode #9 I was very interested in hearing and outers (the investment part) I wasn’t interested in. I did not see a way to skip the sections I wasn’t interested in — maybe there is one, or if none exists, it would be helpful to provide one (or a lesson / reference on a technical way fro me to solve my own problem).

    Thanks for the interesting ____cast.

Comments are closed.